NeoVolta Inc.: Form 10-Q for the period ended Mar 31, 2025
Filed with the SEC on May 9, 2025 and accepted by EDGAR at May 9, 2025, 16:30 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2025-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2025-01-01 to 2025-03-31 | $2.0m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2024-07-01 to 2025-03-31 | $3.7m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2025-01-01 to 2025-03-31 | $1.5m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2024-07-01 to 2025-03-31 | $2.7m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2025-01-01 to 2025-03-31 | $514.5k | us-gaap:GrossProfit |
| Gross profit | 9 months2024-07-01 to 2025-03-31 | $931.3k | us-gaap:GrossProfit |
| Research and development | 3 months2025-01-01 to 2025-03-31 | $27.9k | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2024-07-01 to 2025-03-31 | $78.9k | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2025-01-01 to 2025-03-31 | −$1.4m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2024-07-01 to 2025-03-31 | −$3.3m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2025-01-01 to 2025-03-31 | $78.5k | us-gaap:InterestExpenseNonoperating |
| Interest expense | 9 months2024-07-01 to 2025-03-31 | $103.0k | us-gaap:InterestExpenseNonoperating |
| Net income | 3 months2025-01-01 to 2025-03-31 | −$1.4m | us-gaap:NetIncomeLoss |
| Net income | 9 months2024-07-01 to 2025-03-31 | −$3.4m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2025-01-01 to 2025-03-31 | −$0.04 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2024-07-01 to 2025-03-31 | −$0.10 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2025-01-01 to 2025-03-31 | −$0.04 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2024-07-01 to 2025-03-31 | −$0.10 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2025-01-01 to 2025-03-31 | 33,640,829 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2024-07-01 to 2025-03-31 | 33,412,117 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2024-07-01 to 2025-03-31 | −$3.5m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Cash and equivalents | At period end2025-03-31 | $536.0k | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2025-03-31 | $5.7m | us-gaap:AssetsCurrent |
| Total assets | At period end2025-03-31 | $5.7m | us-gaap:Assets |
| Current liabilities | At period end2025-03-31 | $1.5m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2025-03-31 | $1.9m | us-gaap:Liabilities |
| Short-term borrowings | At period end2025-03-31 | $1.4m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2025-03-31 | $3.8m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001683168-25-003355. Last ingested by Listed: Nov 4, 2026, 16:38 ET. Listed shows no prices and gives no investment advice.